Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
441
-
442
-
443
-
444
-
445
-
446
-
447
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: -
448
-
449
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: -
450
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
Published 2025Subjects: -
451
-
452
-
453
-
454
-
455
Baseline characteristics of the study participants and the results of laboratory measurements.
Published 2024Subjects: -
456
-
457
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
Published 2024Subjects: -
458
Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).
Published 2024Subjects: -
459
-
460